Status epilepticus is a life-threatening medical condition. In its most severe form, refractory status epilepticus (RSE) seizures may not respond to first and second-line anti-epileptic drugs. RSE is associated with a high mortality and significant medical complications in survivors with prolonged hospitalizations.
We describe the clinical course of RSE in the setting of new onset lupus in a 31-year-old male who required prolonged barbiturate coma.
Seizure stopped on day 64 of treatment. Prior to the resolution of seizures, discussion around withdrawal of care took place between the physicians and patient's family. Medical care was continued because of the patient's age, normal serial MRI studies, and the patient's reversible medical condition.
Few evidence-based data exist to guide management of RSE. Our case emphasizes the need for continuous aggressive therapy when neuroimaging remains normal.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Lawn ND, Wijdicks EF. Progress in clinical neurosciences: Status epilepticus: a critical review of management options. Can J Neurol Sci 2002;29:206–215.
Mayer SA, Claassen J, Lokin, J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205–210.
Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993;22:1337–1348.
Bleck TP. Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955–957.
Claassen J, Lokin JK, Fitzsimmons BF, Mendelsohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology 2002;58:139–142.
Mirski MA, Williams MA, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995;23:400–404.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
Moder KG. Use of ACR Classification Criteria for SLE at a Tertiary Care Center. Arthritis Rheum 2003;48:S584.
Moder KG. Immunologic tests, in rheumatology. Ann Allergy Asthma Immunol 1998;81:539–544 547; quiz 547–538.
Brinciotti M, Ferrucci G, Trasatti G, et al. Reflex seizures as initial manifestations of systemic lupus erythematosus in childhood. Lupus 1993;2:281–283.
Hermosillo-Romo D, Brey RL. Neuropsychiatric involvement in systemic lupus erythematosus. Curr Rheumatol Rep 2002;4: 337–344.
Brey RL, Petri MA. Neuropsychiatric systemic lupus erythematosus: miles to go before we sleep. Neurology 2003;61:9–10.
Noe KH, Manno EM. Mechanisms underlying status epilepticus. Drugs Today (Barc) 2005;41:257–266.
Bleck TP. Refractory status epilepticus in 2001. Arch Neurol 2002;59:188–189.
Brook I, Hulburd CS. Pseudomonas aeruginosa iatrogenic blepharoconjunctivities. Arch Ophthalmol 1993;111:26–27.
Tejada J, Hernandez-Echebarria LE, Fernandez-Lopez JE, et al. Acute anterior horn cell disease resembling poliomyelitis as a manifestation of respiratory syncytial virus infection. J Neurol Neurosurg Psychiatry 1996;60:106–107.
Dara SI, Afessa B, Bajwa AA, Albright RC. Outcome of patients with end-stage renal disease admitted to the intensive care unit. Mayo Clin Proc 2004;79:1385–1390.
Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 1987;37:500–503.
About this article
Cite this article
Dara, S.I., Tungpalan, L.A., Manno, E.M. et al. Prolonged coma from refractory status epilepticus. Neurocrit Care 4, 140–142 (2006). https://doi.org/10.1385/NCC:4:2:140
- refractory status epilepticus (RSE)